• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Neurologix Inc

+ Add to Watchlist

NRGXQ:US

0.0015 USD 0.00000.00%

As of 20:10:00 ET on 04/15/2014.

Snapshot for Neurologix Inc (NRGXQ)

Open: - Day's Range: - Volume: 20,000
Previous Close: 0.0015 52wk Range: 0.0003 - 0.0100 1-Yr Rtn: +33.33%

Stock Chart for NRGXQ

No chart data available.
  • NRGXQ:US 0.0015
  • 1D
  • 1M
  • 1Y
0.0015
Interactive NRGXQ Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NRGXQ

Current P/E Ratio (ttm) -
Estimated P/E(12/2011) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.4400
Est. EPS (USD) (12/2011) -
Est. PEG Ratio -
Market Cap (M USD) 0.04
Shares Outstanding (M) 28.00
30 Day Average Volume 8,990
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NRGXQ

No data available

Company Profile & Key Executives for NRGXQ

Neurologix, Inc. is developing treatments for disorders of the brain and central nervous system using gene therapy and other alternative therapies. The Company's initial development efforts are focused on gene therapy for treating Parkinson's disease and epilepsy. Neurologix's core technology, NLX, is currently being tested in a human clinical trial to treat Parkinson's disease.

Clark A JohnsonChairman/CEOChristine V SapanExec VP/Chief Development Ofcr
More Company Profile & Key Executives for NRGXQ

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil